Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Risks associated with the use of non-steroidal anti-inflammatory drugs during pneumonia

Abstract : Introduction. -Outpatient treatment of community-acquired pneumonia (CAP) patients with non-steroidal anti-inflammatory drugs (NSAIDs) is frequent, although this is not based on clinical recommendations and there is no scientific evidence supporting better symptom relief in comparison to acetaminophen. State of the art. -Experimental data suggest that NSAIDs alter the intrinsic functions of neutrophils, limit their locoregional recruitment, alter bacterial clearance and delay the resolution of inflammatory processes during acute bacterial pulmonary challenge. In hospitalized children and adults with CAP, observational data suggest a strong and independent association between the outpatient exposure to NSAIDs and the occurrence of pleuropulmonary complications (pleural empyema, excavation, and abscess). In the only study taking into account possible protopathic bias, the association still persists. Other markers of morbidity have been described, including delay in hospital management, prolonged antibiotic therapy, and higher transfer rate to an intensive care unit. Perspectives. -Data describing the role of self-medication and the biological mechanisms involved are needed. Conclusions. -Intake of NSAIDs during outpatient treatment of CAP is probably the second modifiable factor of morbidity after inadequate antibiotic therapy. In light of existing data in children and adults, health authorities should urgently reassess the risk-benefit ratio of NSAIDS in CAR (C) 2018 SPLF. Published by Elsevier Masson SAS. All rights reserved.
Type de document :
Article dans une revue
Liste complète des métadonnées
Contributeur : Louise DESSAIVRE Connectez-vous pour contacter le contributeur
Soumis le : lundi 28 février 2022 - 15:23:59
Dernière modification le : vendredi 2 septembre 2022 - 17:13:44



G. Voiriot, M. Chalumeau, J. Messika, Damien Basille, B. Philippe, et al.. Risks associated with the use of non-steroidal anti-inflammatory drugs during pneumonia. Revue des Maladies Respiratoires, Elsevier Masson, 2018, 35 (4), pp.430-440. ⟨10.1016/j.rmr.2017.12.003⟩. ⟨hal-03591333⟩



Consultations de la notice